Literature DB >> 22045272

Mapping utility scores from the Barthel index.

Billingsley Kaambwa1, Lucinda Billingham, Stirling Bryan.   

Abstract

PURPOSE: It is not always possible to collect utility-based outcome data, like EQ-5D, needed for conducting economic evaluations in populations of older people. Sometimes, information on other non-utility outcome measures may have been collected. This paper examines the possibility of mapping the EQ-5D from a non-utility-based outcome, the Barthel index.
METHODS: Data for 1,189 UK intermediate care patients were used. Ordinary least squares (OLS), censored least absolute deviations (CLAD) estimator and multinomial logistic (ML) models were used. The mean absolute error (MAE) and root-mean-squared error (RMSE) were used to estimate the predictive accuracy of eight regression models. Validation of primary models was carried out on random samples of data collected at admission and discharge.
RESULTS: Models where the EQ-5D was entered as a continuous dependent variable and Barthel dimensions used as explanatory variables performed better. CLAD performed best on MAE and OLS on the RMSE, while the ML performed the worst on both measures. The CLAD predicted EQ-5D scores that matched the observed values more closely than the OLS.
CONCLUSIONS: It is possible to reasonably predict that the EQ-5D from the Barthel using regression methods and the CLAD model (4) is recommended.

Entities:  

Mesh:

Year:  2011        PMID: 22045272     DOI: 10.1007/s10198-011-0364-5

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  41 in total

Review 1.  A review of the use of health status measures in economic evaluation.

Authors:  J Brazier; M Deverill; C Green; R Harper; A Booth
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

2.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

3.  Proxy and self-report agreement on the Stroke and Aphasia Quality of Life Scale-39.

Authors:  Katerina Hilari; Sophie Owen; Sharon Jane Farrelly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-26       Impact factor: 10.154

4.  Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration.

Authors:  Nalin Payakachat; Kent H Summers; Andreas M Pleil; Matthew M Murawski; Joseph Thomas; Kristofer Jennings; James G Anderson
Journal:  Qual Life Res       Date:  2009-06-19       Impact factor: 4.147

5.  Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index.

Authors:  Yin-Bun Cheung; Julian Thumboo; Fei Gao; Gim-Yew Ng; Grace Pang; Wen-Hsin Koo; Vijay-Kumar Sethi; Joseph Wee; Cynthia Goh
Journal:  Value Health       Date:  2008-09-09       Impact factor: 5.725

6.  Use of the EuroQoL among elderly acute care patients.

Authors:  J Coast; T J Peters; S H Richards; D J Gunnell
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

7.  Economic analysis of an early discharge rehabilitation service for older people.

Authors:  P Miller; J R F Gladman; A L Cunliffe; S L Husbands; M E Dewey; R H Harwood
Journal:  Age Ageing       Date:  2005-03-11       Impact factor: 10.668

Review 8.  Reliability of the Barthel Index when used with older people.

Authors:  Anita Sainsbury; Gudrun Seebass; Aruna Bansal; John B Young
Journal:  Age Ageing       Date:  2005-05       Impact factor: 10.668

9.  Assessment of post-stroke quality of life in cost-effectiveness studies: the usefulness of the Barthel Index and the EuroQoL-5D.

Authors:  N J A van Exel; W J M Scholte op Reimer; M A Koopmanschap
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

10.  Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease.

Authors:  I-Chan Huang; Constantine Frangakis; Mark J Atkinson; Richard J Willke; Walter L Leite; W Bruce Vogel; Albert W Wu
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

View more
  17 in total

1.  Trajectory of functional decline before and after ischemic stroke: the Northern Manhattan Study.

Authors:  Mandip S Dhamoon; Yeseon P Moon; Myunghee C Paik; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2012-05-29       Impact factor: 7.914

Review 2.  An educational review of the statistical issues in analysing utility data for cost-utility analysis.

Authors:  Rachael Maree Hunter; Gianluca Baio; Thomas Butt; Stephen Morris; Jeff Round; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

3.  Mapping EQ-5D utility scores from the PedsQL™ generic core scales.

Authors:  Kamran A Khan; Stavros Petrou; Oliver Rivero-Arias; Stephen J Walters; Spencer E Boyle
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

4.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).

Authors:  Billingsley Kaambwa; Gang Chen; Julie Ratcliffe; Angelo Iezzi; Aimee Maxwell; Jeff Richardson
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

5.  Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.

Authors:  Billingsley Kaambwa; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

6.  Mapping the Shah-modified Barthel Index to the Health Utility Index Mark III by the Mean Rank Method.

Authors:  Yin Bun Cheung; Hui Xing Tan; Nan Luo; Hwee Lin Wee; Gerald C H Koh
Journal:  Qual Life Res       Date:  2019-07-27       Impact factor: 4.147

Review 7.  Comprehensive geriatric assessment for older adults admitted to hospital.

Authors:  Graham Ellis; Mike Gardner; Apostolos Tsiachristas; Peter Langhorne; Orlaith Burke; Rowan H Harwood; Simon P Conroy; Tilo Kircher; Dominique Somme; Ingvild Saltvedt; Heidi Wald; Desmond O'Neill; David Robinson; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

8.  The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.

Authors:  Stavros Petrou; Oliver Rivero-Arias; Helen Dakin; Louise Longworth; Mark Oppe; Robert Froud; Alastair Gray
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

9.  Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group.

Authors:  Dominique A Cadilhac; Joosup Kim; Alastair Wilson; Eivind Berge; Anita Patel; Myzoon Ali; Jeffrey Saver; Hanne Christensen; Matthieu Cuche; Sean Crews; Olivia Wu; Marine Provoyeur; Peter McMeekin; Isabelle Durand-Zaleski; Gary A Ford; Natalia Muhlemann; Philip M Bath; Azmil H Abdul-Rahim; Katharina Sunnerhagen; Atte Meretoja; Vincent Thijs; Christian Weimar; Ayrton Massaro; Annemarei Ranta; Kennedy R Lees
Journal:  Eur Stroke J       Date:  2020-01-27

10.  Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.

Authors:  Takumi Ashizawa; Ataru Igarashi; Yukinori Sakata; Mie Azuma; Kenichi Fujimoto; Tsukasa Kobayashi; Yoshimasa Takase; Shunya Ikeda
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.